Currently, the share price for Orchid Pharma Ltd. is delayed. Login to view live prices.
Orchid Pharma Ltd.
₹1,699.30
NSE
-- ( -- %) 1D
- Prev. Close1,699.30
- Upper Circuit2,039.15
- Lower Circuit1,359.45
Analyst Sentiment For Orchid Pharma Ltd.
There seem to be no recommendations on this stock from the analyst universe covered
Returns
Orchid Pharma Ltd.'s Info & Management
Orchid Pharma is one of the leading pharmaceutical companies in India head quartered in Chennai and involved in the development, manufacture and marketing of diverse bulk actives, formulations and nutraceuticals with exports spanning over 40 countries.
- Chief Executive Officer - Orchid AMSMr. Rajnish Rohatgi
- Vice President - Unit Head-API &FDFMr. Sarangdhar R J
- Head - Medico MarketingMr. Prabhu Vinayagam
- Chief Financial OfficerMr. Sunil Kumar Gupta
- Head(CTD,IPM)Mr. Srinivasan S
- General Manager(Quality Control)Mr. Thirunavukkarasu R
FAQs on Orchid Pharma Ltd.
What is the share price of Orchid Pharma Ltd.?
Orchid Pharma Ltd. share price is ₹1,693.30 as of December 13, 2024, 10:28 AM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).
What is the 52-week high and low of Orchid Pharma Ltd.?
The 52-week high and low of Orchid Pharma Ltd. is ₹1,785.75 and ₹635.30 respectively as of December 13, 2024, 10:28 AM.
52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).
What is the PB ratio of Orchid Pharma Ltd.?
The trailing twelve month (TTM) PB ratio of Orchid Pharma Ltd. is 7.83 as of December 13, 2024. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.
What are the Upper Circuit and Lower Circuit of Orchid Pharma Ltd.?
The Upper Circuit of Orchid Pharma Ltd. is ₹2,039.
The Lower Circuit of Orchid Pharma Ltd. is ₹1,359.
What is the ROE of Orchid Pharma Ltd.?
Orchid Pharma Ltd. reported an ROE of 10.71% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.
What is the shareholding pattern of Orchid Pharma Ltd.?
Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Orchid Pharma Ltd., Promoter held 69.8%, the FII held 1.9%, DII held 18.3% and the public held 9.9% of the total shares.
How to buy Orchid Pharma Ltd. Share?
You can easily buy shares of Orchid Pharma Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.
What is the fair value of Orchid Pharma Ltd.?
The fair value of Orchid Pharma Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer